Chevron
Go back
BridgeBio Pharma logo

BridgeBio Pharma

Since January 1, 2014
BridgeBio Pharma focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D.
Icon, Palo Alto, United States
Palo Alto, United States
Icon, 251 — 500 employees
251 — 500 employees
Icon, Raised $624.2M
Raised $624.2M
Biotechnology
Health Care
Life Science
Medical
Pharmaceutical
Post-IPO Equity
March 5, 2023
$150M
See all investors and rounds